Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT01028404
Eligibility Criteria:
Inclusion Criteria:
* FOR TRIAL PART 1, THE FOLLOWING APPLIES:
* Gender: male
* Age: 18-55 years
* BMI (body mass index): 18-28 kg/m2
* Study participants considered to be healthy
* FOR TRIAL PART 2, THE FOLLOWING APPLIES:
* Gender: male or female of no childbearing potential
* Age: 18-65 years
* Type 1 diabetes: BMI (body mass index): 18-28 kg/m2
* Type 2 diabetes: BMI (body mass index): 22-35 kg/m2
* Type 1 or type 2 diabetes for at least 12 months
* Type 1 diabetes: Treatment with insulin for at least 12 months
* Type 2 diabetes: Treatment with insulin for at least 3 months
Exclusion Criteria:
* Known or suspected allergy to the trial product or related products
* Presence of illness or infection that may confound the results of the study or pose a risk to the study participant by dosing NN1952, as judged by the Investigator
* Presence of acute gastrointestinal symptoms (for example nausea, vomiting, heartburn or diarrhoea)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01028404
Study Brief:
Protocol Section:
NCT01028404